Compound Detail
CHEMBL5633067
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5633067 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DFSDQJWWAXBBHO-UHFFFAOYSA-N |
1
Targets
5
Activities
1
Assay Types
21
PK Parameters
15
Publications
0
Known Names
Molecular Properties
467.5
MW (Da)
3.02
ALogP
10
HBA
1
HBD
118.1
PSA (Ų)
0.31
QED
0
Ro5 Violations
12
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 9.72
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 9.72 | 8.965 | 0.2 | 4 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1919.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1923.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1531.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1542.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 17.4 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 33.4 | mL.min-1.g-1 | Mus musculus |
| CL | 53.6 | mL.min-1.kg-1 | Mus musculus |
| CL | 132.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 0.444 | ug.mL-1 | Rattus norvegicus |
| F | 32.0 | % | Rattus norvegicus |
| MRT | 1.16 | hr | Rattus norvegicus |
| MRT | 2.48 | hr | Rattus norvegicus |
| T1/2 | 0.93 | hr | Rattus norvegicus |
| T1/2 | 0.81 | hr | Rattus norvegicus |
| T1/2 | 0.4933 | hr | Mus musculus |
| T1/2 | 8.0 | hr | - |
| T1/2 | 8.0 | hr | - |
| T1/2 | 24.0 | hr | - |
| T1/2 | 12.0 | hr | - |
| Tmax | 2.33 | hr | Rattus norvegicus |
| Vd | 1.4 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor | IC50 | = | 0.19 | nM | 9.72 | Irreversible covalent inhibition of recombinant full length EGFR (unknown origin... | 37499291 |
| Epidermal growth factor receptor | IC50 | = | 0.25 | nM | 9.6 | Inhibition of EGFR C797S mutant (unknown origin) by kinomescan analysis | 37499291 |
| Epidermal growth factor receptor | IC50 | = | 0.83 | nM | 9.08 | Irreversible covalent inhibition of recombinant full length EGFR (unknown origin... | 37499291 |
| Epidermal growth factor receptor | IC50 | = | 35.1 | nM | 7.46 | Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 r... | 37499291 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37499291 | 10.1016/j.ejmech.2023.115671 | ADMET | 25 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Epidermal growth factor receptor | 15 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | No relevant target | 4 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Cytochrome P450 1A2 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Cytochrome P450 2C9 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Cytochrome P450 2C19 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Cytochrome P450 2D6 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Cytochrome P450 3A4 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | HCC827 | 2 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | BaF3 | 1 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | NCI-H3255 | 1 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | NCI-H1975 | 1 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | A-431 | 1 |
| 37499291 | 10.1016/j.ejmech.2023.115671 | HEK293 | 1 |
Data from ChEMBL 36 via Core Engine